In vitro studies on the activity of amphotericin B and lipid‐based amphotericin B formulations against Aspergillus conidia and hyphae
- 1 June 2002
- Vol. 45 (5-6), 166-169
- https://doi.org/10.1046/j.1439-0507.2002.00748.x
Abstract
The minimum inhibitory concentrations (MICs) of amphotericin B and lipid-based amphotericin B formulations against isolates of Aspergillus spp. were tested using a broth microdilution method. Twelve isolates of Aspergillus fumigatus, eight of Aspergillus flavus, six of Aspergillus niger and seven of Aspergillus terreus were examined. In addition, an assay for hyphae of Aspergillus spp. was performed since the invasive form is manifested by the appearance of hyphal structures. MICs of hyphae against lipid-based amphotericin B formulations were within three dilutions higher than those against conidia for almost all isolates of Aspergillus spp. (P < 0.01). In contrast, the differences in the in vitro efficacies of amphotericin B were the lowest for Aspergillus spp. This study demonstrates the importance of the type of inoculum used to test antifungal susceptibilities of Aspergillus spp. The significance of these results for in vivo outcome needs to be determined.Keywords
This publication has 18 references indexed in Scilit:
- Studies of In Vitro Activities of Voriconazole and Itraconazole against Aspergillus Hyphae Using Viability StainingAntimicrobial Agents and Chemotherapy, 2001
- Comparison of In Vitro Activity of Liposomal Nystatin against Aspergillus Species with Those of Nystatin, Amphotericin B (AB) Deoxycholate, AB Colloidal Dispersion, Liposomal AB, AB Lipid Complex, and ItraconazoleAntimicrobial Agents and Chemotherapy, 1999
- Invasive AspergillosisClinical Infectious Diseases, 1998
- Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungiAntimicrobial Agents and Chemotherapy, 1995
- Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patientsAntimicrobial Agents and Chemotherapy, 1994
- Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin BEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Pulmonary Aspergillosis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1991
- Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised hostJournal of Antimicrobial Chemotherapy, 1991
- Nosocomial Fungal Infections: A Classification for Hospital-Acquired Fungal Infections and Mycoses Arising from Endogenous Flora or ReactivationAnnual Review of Microbiology, 1988
- Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin BAntimicrobial Agents and Chemotherapy, 1988